Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Pignon

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
JAMA|May 6, 2010
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis, Xavier Paoletti, Koji Oba, et al.
Oncotarget|April 28, 2017
Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patientsAngela Boros, Ludovic Lacroix, Benjamin Lacas, et al.
Journal of Neuro-Oncology|May 16, 2015
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survivalMarcos A dos Santos, Jean-Pierre Pignon, Pierre Blanchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer groupPierre Blanchard, Jean Bourhis, Benjamin Lacas, et al.
The Oncologist|June 19, 2012
Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinomaValérie Boige, David Malka, Abderrahmane Bourredjem, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinomaNader Abedallaa, Lise Tremblay, Charlotte Baey, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2013
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITAStephen L Graziano, Benjamin Lacas, Robin Vollmer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2020
Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastasesAlice Boilève, Astrid De Cuyper, Alicia Larive, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patientsBram L T Ramaekers, Manuela A Joore, Béranger Lueza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trialMarc Ychou, Valérie Boige, Jean-Pierre Pignon, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
JAMA|May 6, 2010
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis, Xavier Paoletti, Koji Oba, et al.
Oncotarget|April 28, 2017
Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patientsAngela Boros, Ludovic Lacroix, Benjamin Lacas, et al.
Journal of Neuro-Oncology|May 16, 2015
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survivalMarcos A dos Santos, Jean-Pierre Pignon, Pierre Blanchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer groupPierre Blanchard, Jean Bourhis, Benjamin Lacas, et al.
The Oncologist|June 19, 2012
Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinomaValérie Boige, David Malka, Abderrahmane Bourredjem, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinomaNader Abedallaa, Lise Tremblay, Charlotte Baey, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2013
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITAStephen L Graziano, Benjamin Lacas, Robin Vollmer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2020
Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastasesAlice Boilève, Astrid De Cuyper, Alicia Larive, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patientsBram L T Ramaekers, Manuela A Joore, Béranger Lueza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trialMarc Ychou, Valérie Boige, Jean-Pierre Pignon, et al.
Pageof 15